Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

381results about "Tripeptides" patented technology

Antibody-drug conjugate, preparation method therefor, and use thereof

Provided are an antibody-drug conjugate, a preparation method therefor, and use thereof. The antibody-drug conjugate has a structure represented by the formula Ab-[M-L-E-D]x, has a superior drug-to-antibody ratio, and has an excellent targeted killing effect on various cancers or tumors.
Owner:SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD

Preparation method of collagen tripeptide and obtained product

The invention belongs to the field of biomedical materials, and particularly relates to a preparation method of collagen tripeptide and an obtained product. Compared with the prior art, the method has the advantages that by adding alkali to soak the cowhide particles and combining treatment means such as denaturation and enzymolysis, the destroy denaturation of a triple helix structure of collagen in the cowhide can be promoted, the collagen can be thoroughly subjected to enzymolysis, so that the yield of collagen tripeptide is higher, the molecular weight is small and concentrated, and meanwhile, the foreign flavor in the cowhide can be effectively removed; subsequently, mixed enzymes jointly act on collagen peptide bonds, so that generation of collagen tripeptide is facilitated; in the operation process of the method, acid or alkali does not need to be added for multiple times to adjust the pH, and the generated collagen tripeptide is low in ash content; after suction filtration and impurity removal, impurities in the collagen tripeptide are reduced, and the yield of the obtained collagen tripeptide freeze-dried product is high; under the synergistic effect of all the treatment processes, the prepared product is fine and smooth in component, free of fishy smell and foreign flavor and good in water solubility.
Owner:济南磐升生物技术有限公司

Anti-wrinkle combined cyclic peptide and application thereof in cosmetics

The invention provides an anti-wrinkle combined cyclic peptide and application thereof in cosmetics, the anti-wrinkle combined cyclic peptide comprises cyclic pentapeptide-4, cyclic tripeptide-5 and cyclic hexapeptide-9, the combined cyclic peptide has a remarkable synergistic effect in the aspects of promoting expression of collagen genes Collagen I, Collagen III and Collagen IV and inhibiting acetylcholine secretion, the skin elasticity and glossiness are remarkably improved, and the anti-wrinkle combined cyclic peptide has a good anti-wrinkle effect. The generation of wrinkles is inhibited, and good anti-aging and wrinkle-removing effects are achieved.
Owner:SHANGHAI ZHONGYI DAILY CHEM CO LTD +1

Collagen tripeptide as well as preparation method and application thereof

The invention provides collagen tripeptide as well as a preparation method and application thereof, and belongs to the technical field of active peptide. The invention provides a preparation method of collagen tripeptide, which comprises the following steps: carrying out enzymolysis treatment on tilapia scales and high-temperature-resistant protease, then carrying out enzymolysis treatment by using alkaline protease and neutral protease in sequence, filtering enzymatic hydrolysate by using a ceramic membrane and an organic filter membrane in sequence, and intercepting by using a 400Da nanofiltration membrane to obtain collagen tripeptide. The permeate contains active peptide mainly composed of collagen tripeptide. After the permeate is concentrated and dried, the collagen tripeptide powder is detected, and the protein content reaches 96.2%, the GPH content is 3.8%, and the CTP content is 35.09%. The collagen tripeptide powder has better DPPH (1, 1-diphenyl-2-picrylhydrazyl) scavenging activity; the traditional Chinese medicine composition has an obvious ROS removing effect, a beta-galactosidase activity inhibiting effect and a telomerase activity enhancing promoting effect on a hydrogen peroxide induced zebrafish aging model, and shows an obvious anti-aging effect.
Owner:ZHONGSHI DUQING(SHANDONG) BIOTECH CO LTD

Antibody-drug conjugate, method for preparing same, and use thereof

Provided are an antibody-drug conjugate, a method for preparing same, and use thereof. The antibody-drug conjugate has a structure represented by formula Ab-[M-L-E-D] x, a superior drug-to-antibody ratio, and an excellent targeted killing effect on various cancers or tumors.
Owner:SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD

New antithrombotic antibodies

The present invention provides a novel antithrombotic antibody, which targets FIXa and has unique properties, specifically targets the binding site of blood coagulation factors FIXa and FVIIIa, reduces the formation of FVIIIa-FIXa complex, blocks the conversion of FX to FXa, and exerts antithrombotic effects. The antibody of the present invention has suitable antithrombotic properties, has a wide effective therapeutic concentration window, but does not increase the risk of bleeding; it can realize the demand for moderate antithrombotic properties in clinical applications and effectively avoid bleeding problems caused by excessive effects. The present invention also discloses a method for screening drugs that target the FIXa-FVIIIa binding site.
Owner:SHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD

Camptothecin derivative

Disclosed herein are novel cytotoxic compounds, and cytotoxic conjugates comprising these cytotoxic compounds and cell binding agents. More specifically, the present disclosure relates to novel camptothecin derivatives thereof, intermediates thereof, conjugates thereof, and pharmaceutically acceptable salts thereof, which are useful as medicaments, particularly as antiproliferative agents (anticancer agents).
Owner:IMMUNOGEN INC

Use of anti-aging glycopeptides for the treatment of dry eye disease, retinal degenerative disease, or ocular inflammation

Use of anti-aging glycopeptides for the treatment of dry eye disease, retinal degenerative disease, or ocular inflammation [Solution] The present specification discloses methods of using a gem-difluorinated C-glycopeptide compound represented by general formula I, or a pharmaceutically acceptable base, acid addition salt, hydrate or solvate of a compound represented by general formula I, for the treatment or prevention of dry eye disease, and / or for the treatment or prevention of retinal degenerative disease, ocular inflammation, or a combination thereof in a subject in need of such treatment or prevention.
Owner:PROTOKINETIX INC

PSMA binding ligand-linker conjugates and methods for using

Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.
Owner:PURDUE RES FOUND

Preparation method and application of collagen tripeptide liquid

The invention relates to a preparation method and application of collagen tripeptide liquid, and belongs to the technical field of bioactive peptides, the preparation method comprises the following steps: A1, pretreating fish skin raw materials to obtain fish skin homogenate; a2, the pH value of the fish skin homogenate is adjusted to be neutral, compound protease accounting for 1-4% of the mass of the fish skin is added for enzymolysis, and a collagen peptide crude extracting solution is obtained; a3, performing enzyme deactivation and centrifugation, collecting supernate, and performing nanofiltration to obtain a filtered component 1 and an intercepted component 1; a4, putting the interception component 1 into a hydrochloric acid solution, and hydrolyzing to obtain hydrolysate; adjusting the hydrolysate to be neutral, and then carrying out nanofiltration to obtain a filtered component 2 and an intercepted component 2; and A5, mixing the filtered component 1 and the filtered component 2, carrying out nanofiltration, and collecting an intercepted component 3 to obtain a collagen tripeptide solution. The collagen tripeptide in the prepared collagen tripeptide liquid is high in yield, and the purity is also effectively improved.
Owner:WEIMING TAIYAN BIOTECHNOLOGY (SHAOXING) CO LTD

Radiolabeled compounds targeting prostate-specific membrane antigen - Patents.com

A compound comprising a prostate-specific membrane antigen (PSMA) targeting moiety of the following formula: R 0 is O or S. 1a , R 1b and R 1c Each of R may be, for example, —COH, —SOH, —SOH, —POH, or —POH. 2 R may be an optionally substituted methylene or a derivative thereof, propylene or a derivative thereof, or a derivative of ethylene. 3 is a linker. When the PSMA targeting moiety is attached to a radiolabeling group, the compound may be used as an imaging agent or a therapeutic agent for diseases / conditions that express PSMA. TIFF2022537773000240.tif2237
Owner:PROVINCIAL HEALTH SERVICES AUTHORITY +1

Antibody-auristatins drug conjugate and use thereof

An antibody-drug conjugate as shown in formula I, a preparation method therefor, and a use thereof in prevention and / or treatment of diseases related to abnormal cell activity, including but not limited to a use in prevention and / or treatment of tumor diseases.
Owner:MEDILINK THERAPEUTICS (SUZHOU) CO LTD

Camptothecin compound, preparation method therefor and use thereof

The present invention relates to a camptothecin compound with anti-tumor activity, a preparation method therefor and use thereof. In particular, the present invention relates to a compound of the following formula or a pharmaceutically acceptable form thereof, a pharmaceutical composition thereof, a preparation method thereof and use thereof. The compound can be used as a medicine for treating diseases in abnormal cell proliferation,
Owner:SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD

SIV envelope trimer

The present application relates to epitope-targeted SIV and HIV vaccines. The invention provides novel envelope glycoproteins which may be utilized as HIV-1 vaccine immunogens, antigens for crystallization, and for identification of broadly neutralizing antibodies. The invention encompasses preparation and purification of immunogenic compositions which are formulated into vaccines of the present invention.
Owner:THE SCRIPPS RES INST

CAIX targeted degradation agent as well as preparation method and application thereof

The invention discloses a CAIX targeted degradation agent. The CAIX targeted degradation agent comprises a CAIX target protein ligand, an integrin ligand and a connector, the CAIX target protein ligand and the integrin ligand are connected through the connecting body. As the carbonic anhydrase IX is enriched in the tumor region, the CAIX targeted degradation agent can specifically target the tumor region; the compound can effectively induce degradation of CAIX and inhibit survival of tumor cells under the hypoxia condition, has the functions of targeting a tumor area and degrading carbonic anhydrase IX by utilizing integrin and lysosome, further changes hypoxia and subacid environments of the internal environment of a tumor patient, and plays a role in inhibiting survival of hypoxia tumor cells; the tumor targeting property is high, the toxic and side effects on normal cells are relatively small, and a relatively good effect can be obtained by using a relatively small dosage.
Owner:SHENZHEN INST OF ADVANCED TECH

Compounds useful for the treatment and / or care of the skin, hair, nails and / or mucous membranes

The present invention relates to a compound of formula (I) R1-W m -X n -AA i -AA2-AA3-AA4-AA5-AA6-Y p -Z q -R a wherein AA1 is Asp, Gly, Asn, Gln, Ala, or no amino acid, AA2 is Val, Ile, Leu, or Ala, AA3 is Tyr, Phe, Trp, Lys, Arg, or His, AA4 is Lys, Arg, His, Pro, or Val, AA5 is Asn, Asp, Gln, or no amino acid, and AA6 is Thr, Ala, Ser, or no amino acid. The compounds are useful for treating and / or preventing symptoms of skin aging, in particular for treating and / or preventing skin wrinkles, treating and / or preventing the appearance of sagging skin, and / or reducing and / or preventing facial asymmetry.
Owner:LUBRIZOL ADVANCED MATERIALS INC

Antibody conjugates for targeting Trop-2-expressing tumors

The present invention relates to an antibody conjugate that is particularly suitable for targeting Trop-2 expressing cells, especially tumor cells. The antibody conjugate according to the invention has the structure (1), where AB is an antibody capable of targeting Trop-2 expressing tumors, L is a linker connecting Z to D, Z is a connecting group, and L 6 -GlcNAc(Fuc) w -(G) j -S-(L 7 ) w’ -, in which G is a monosaccharide, j is an integer ranging from 0 to 10, S is a sugar or a sugar derivative, GlcNAc is N-acetylglucosamine, Fuc is fucose, w is 0 or 1, w' is 0, 1, or 2, and L 7 is -N(H)C(O)CH2-, -N(H)C(O)CF2-, or -CH2-, D is exatecan, b is 0 or 1, x is 1 or 2, and y is 1, 2, 3, or 4. The present invention further relates to methods for preparing the antibody conjugates of structure (1) and applications of the antibody conjugates of structure (1).
Owner:SYNAFFIX BV

Double-residue extension peptide and preparation method thereof

Various peptides having extended double residues can be prepared by reacting a first amino acid or peptide represented by formula (1), a halogenating agent, a tertiary amine represented by formula (3), an amino acid N-carboxylic acid anhydride (NCA) represented by formula (4), and a second amino acid or peptide represented by formula (5). # imgabs0 # # imgabs1 # imgabs2 # imgabs3 #
Owner:NAT UNIV CORP TOKAI NAT HIGHER EDUCATION & RES SYST

Soluble biomolecular glass and its use

The present invention provides biomolecular glass and its use. The biomolecular glass is obtained by volatilizing a solvent from a solution of biomolecular raw materials, the solution of biomolecular raw materials comprising biomolecular raw materials, a modifier, and a solvent. The biomolecular raw materials include natural amino acids, peptides, amino acid derivatives, peptide derivatives, or mixtures of two or more of the above. The soluble biomolecular glass of the present invention has excellent biocompatibility, high light transmittance, good mechanical strength, flexible processability, and biodegradability, and can be processed into implantable or non-implantable medical materials and / or devices, fillers and stent materials, electronic sensing materials and / or devices, temporary electronic materials and / or devices, etc., and can be decomposed by living organisms or nature, with decomposition products being non-contaminating.
Owner:INSTITUTE OF PROCESS ENGINEERING CHINESE ACADEMY OF SCIENCES

Peptide

PendingEP4406961A4highly effective at permeating a cell membranePeptides with abnormal peptide linkBulk chemical production
The present invention provides a peptide having a fluoroalkyl group in the side chain. The present invention provides a peptide in which 2 or more amino acids are peptide-bonded in which at least one side chain of an amino acid residue constituting the peptide is represented by the following General Formula (1) [in the formula, Z1 is a divalent, trivalent, or tetravalent linking group other than an alkylene group; Rf is a C1-30 alkyl group substituted with at least two fluorine atoms, -SF5, or -SF4-CR101R102-CR103R104Cl (R101, R102, R103, and R104 are each independently a hydrogen atom, a fluorine atom, or a chlorine atom, and two or more of R101, R102, R103, and R104 are fluorine atoms); n3 is 1, 2, of 3, and the black circle indicates a bonding site].
Owner:AGC INC +1

Amphiphilic compound, phospholipid structure, and method for producing phospholipid structure

To provide an amphiphilic compound capable of suppressing phase separation of a phospholipid membrane and stabilizing a phospholipid structure.SOLUTION: The present invention provides an amphiphilic compound for use as a stabilizer of two or more phospholipid compounds having different phase transition temperatures, the amphiphilic compound being represented by the following general formula (1).SELECTED DRAWING: Figure 2B
Owner:NAT UNIV CORP TOKYO UNIV OF AGRI & TECH

Antiviral Compounds

The present invention relates to a compound represented by the general formula (I) The present invention provides a viral protease inhibitor having the formula: TIFF2024545135000558.tif3653, wherein the variables are as described herein, compositions comprising the compounds, methods of making the compounds, and methods of using the compounds.
Owner:F HOFFMANN LA ROCHE & CO AG

Methods, compositions and kits for combination therapy

To provide a method of treating an inflammatory neurological disease or condition that can result in destruction or degeneration of axons or myelin.SOLUTION: Provided is a combination comprising a) a compound of formula (I) or a pharmaceutically or veterinarily acceptable salt thereof; and b) one or more drugs selected from the group consisting of I) a compound of a particular formula or a pharmaceutically or veterinarily acceptable salt thereof; ii) a sphingosine-1-phosphate receptor inhibitor (S1PR modulator); and iii) a signal transducer and activator of transcription 3 (STAT3) inhibitor.SELECTED DRAWING: None
Owner:ACCURE THERAPEUTICS SL +1

RNA virus inhibitor compounds with improved metabolic stability and uses thereof

The present disclosure provides compounds with increased metabolic stability for inhibiting a virus infection, such as a Baltimore Group IV RNA virus infection, such as rhinovirus, coxsackievirus, norovirus and coronavirus. Aspects of the present disclosure also include methods of treating the virus infection in a subject with compounds with increased metabolic stability.
Owner:THE GOVERNORS OF THE UNIV OF ALBERTA

Method for forming a porous peptide material

Tripeptides (sequence isomers of K / Y / W) and a method for using the same. The tripeptides, upon a process of evaporation-driven self-assembly, undergo two-stage phase separation to form highly porous particles upon drying. These particles readily re-dissolved upon reintroduction of water. The particles can trap molecular payloads that can be readily released in aqueous media.
Owner:RES FOUND THE CITY UNIV OF NEW YORK

Overdose- and Abuse-Resistant Polysubunit Opioid Prodrugs

To provide constructs such that hydrolysis of the construct by a specified gastrointestinal enzyme directly or indirectly releases an opioid when taken orally as prescribed.SOLUTION: The invention provides constructs such that hydrolysis of the construct by a specified gastrointestinal enzyme directly or indirectly releases an opioid when taken orally as prescribed. The gastrointestinal enzyme mediated release of the opioid from the constructs of the invention is designed to be attenuated in vivo via a saturation or inhibition mechanism when overdoses are ingested. The invention further provides constructs that are highly resistant to oral overdose, chemical tampering, and abuse via non-oral routes of administration.SELECTED DRAWING: Figure 1
Owner:ELYSIUM THERAPEUTICS

Preparation method of fishbone collagen tripeptide

The invention discloses a preparation method of fishbone collagen tripeptide, which comprises the following steps: soaking fishbone dust (30-60 meshes) in a choline-arginine eutectic solvent, stirring, centrifuging or filtering, and collecting supernate; adding pure water with the volume 3-6 times that of the supernatant into the supernatant, standing for more than 24 hours, centrifuging or filtering again, and collecting the supernatant; carrying out tangential filtration treatment by adopting a nanofiltration membrane with the molecular weight cutoff of 200Da, recovering the eutectic solvent in the filtrate through vacuum concentration, adding pure water into the trapped fluid, carrying out repeated nanofiltration treatment to remove solvent residues, and collecting the trapped fluid; and carrying out spray drying on the trapped fluid to obtain a powder product with the collagen tripeptide content of more than 50%. Compared with a traditional enzyme method for preparing fishbone collagen tripeptide, the method disclosed by the invention has the advantages that the extraction rate is high, a deliming step is not needed, the enzyme cost is saved, an extraction solvent is green and can be recycled, and the like.
Owner:SANYA INST OF OCEANOGRAPHY OCEAN UNIV OF CHINA +1

Verrucarin A derivatives and their antibody-drug conjugates

Verrucarin A derivatives, linker-verrucarin A derivatives and antibody-drug conjugates thereof are provided herein. In one embodiment, the verrucarin A derivatives, linker-verrucarin A derivatives and antibody-drug conjugates are useful in treating viral diseases.
Owner:REGENERON PHARMACEUTICALS INC

Hydrophilic tetrazine-functionalized payloads for the preparation of targeted conjugates

The present invention relates to the field of bioconjugation of functional entities (payloads) to targeting agents, in particular biological targeting agents such as antibody drug conjugates (ADCs), in which one or more payload molecules are conjugated to a targeting agent, for example a monoclonal antibody. More specifically, the present invention relates to novel hydrophilic tetrazine molecules and their preparation, which allow more efficient conjugation of payload molecules to targeting agents such as monoclonal antibodies. The present invention also relates to certain tetrazine intermediates useful for the preparation of corresponding functionalized payload molecules. The present invention also relates to the respective conjugates, in particular bioconjugates, and methods for their preparation. The present invention also relates to the medical use of such conjugates of the present invention, to the corresponding pharmaceutical compositions, and to the corresponding diagnostic and analytical kits.
Owner:EURO LAB FUER MOLEKULARBIOLOGIE EMBL +1

Drug delivery systems

ActiveCN118652301BImprove intake efficiencyImprove expression levels in vitroNanomedicineDepsipeptidesPharmacy medicinePharmaceutical drug
The present invention provides a drug delivery system, specifically provides a pharmaceutical carrier lipid conjugate, a pharmaceutical composition containing the lipid conjugate, and its preparation and application, which relates to the field of drug delivery. The lipid conjugate proposed in the present invention can bind to tumor cell surface receptors to improve cell uptake efficiency through structural improvement of the lipid conjugate itself and targeting peptides on the conjugate, thereby improving the expression level.
Owner:RINUAGENE BIOTECHNOLOGY CO LTD